Authors


Nancy Eisenberger, MSN, FNP-C

Latest:

Managing PsA During the COVID-19 Pandemic

Before closing out their discussion on psoriatic arthritis management, two experts consider how the COVID-19 pandemic has affected their practice.


Amreen Dinani, MD; George Therapondos, MD

Latest:

The Battle Against Growing Burden of “Silent” Liver Disease Begins with Early Detection

This article is the first in a series of 4 articles exploring the epidemic of liver disease called nonalcoholic fatty liver disease and its more severe form, nonalcoholic steatohepatitis.


Kostas N. Botsoglou, MD, Rheumatology Center of WNY

Latest:

Prospective Advancements and Final Thoughts on the Treatment of FM

Experts conclude their discussion emphasizing the importance of integrative care and how providers can improve outcomes for their patients with fibromyalgia (FM).


Jamaal Bailey

Latest:

Physician Advice for Patients With SCD

Wally Smith, MD, shares his take-home points for patients with sickle cell disease and urges to get tested for sickle cell trait.


Fariborz Rezai, MD, FCCP FCCM, Rutgers New Jersey Medical School

Latest:

Unmet Needs in OIC Management 

Gerald Sacks, MD, and Fariborz Rezai, MD, FCCP FCCM, discuss unmet needs and the future treatment landscape in managing opioid-induced constipation.


Yazan Abu Omar, MD

Latest:

Bariatric Surgery is Associated with Reduced Risk of Pancreatic Cancer: Analysis of a US National Database

A history of bariatric surgery was associated with up to 50% reduced risk of PDAC among a national cohort.


Robert E. Ratner, MD

Latest:

Effectiveness and Cost-Effectiveness of Diabetes Prevention among Adherent Participants

Over 10 years, lifestyle intervention and metformin were cost-effective or cost saving compared with placebo.


Jonatahn Bertman, MD

Latest:

Tech Talk - Using Common Sense When Selecting an EHR

If one tunes out the background noise and focuses on two simple concepts--affordability and usability--selecting an EHR becomes a lot less confusing.




Alexy V. Pshezhetsky, Ph.D.

Latest:

The Importance of Researcher Involvement in the Rare Disease Community

Alexy V. Pshezhetsky, Ph.D., professor at the University of Montreal. sits down at WORLDSymposium to stress the importance of researcher involvement throughout the rare disease community.


Jill Taylot

Latest:

Best Holiday Wishes

I'd like to send warm wishes out to everyone at the beginning of this holiday season. Enjoy a warm meal, savor a bit of time at home with loved ones, and trade hugs with children outside of the pediatric office, where they are actually happy to see you.



Chris Washburn

Latest:

47th Annual Gastroenterology Update: Biologic Therapies for Inflammatory Bowel Disease, Part 2

Ahmed Kandiel, MD, MPH, at the Cleveland Clinic concluded his lecture, "Which Patient/Which Biologic," by reviewing the results of a recently published meta-analysis which examined the risks and benefits of biologic therapy for patients with moderate-to-severe IBD.








Dava Stewart

Latest:

Choriocapillaris Signal Voids Could Characterize AMD

These signal voids could help clinicians more specifically identify AMD in patients.


Robert J. Anderson, MD: From the Department of Medicine, University of Colorado at Denver

Latest:

Anticoagulation for atrial fibrillation-trends in the United States

The use of anticoagulation therapy for atrial fibrillation has slowly increased in the last decade, yet many patients at relatively high risk for thromboembolic events are still not receiving anticoagulants. Patients receiving therapy that is intended to maintain sinus rhythm may be at higher risk for underuse of anticoagulation therapy than those receiving rate control therapies. In addition, the increase in the use of anticoagulation therapy appears to have been particularly notable among patients for whom it may not be indicated and in whom safer, less expensive antithrombotic therapies would suffice.


Luigi Tavazzi, MD

Latest:

The prognostic role of metabolic syndrome after myocardial infarction

We evaluated the prognostic role of metabolic syndrome after myocardial infarction and found that metabolic syndrome correlated with an increased risk of cardiovascular events and death. The risk of developing diabetes decreased with weight loss in patients with metabolic syndrome. These results indicate that a more aggressive approach to the treatment of patients with metabolic syndrome, particularly with regard to changes in lifestyle, would be beneficial.




Matthias E. Pfisterer, MD: From the Department of Cardiology, University Hospital, Basel, Switzerland.

Latest:

Increased risk of major clinical events late after treatment with drug-eluting stents

We compared the incidence of late clinical events after withdrawal of clopidogrel between subjects treated with drug-eluting stents (DES) and those treated with bare-metal stents. Death and myocardial infarction occurred more frequently among DES-treated subjects during the follow-up period. The results of this study indicate that there may be a penalty for the lower rate of restenosis and reinterventions after DES implantation, in particular, an increased rate of late stent thromboses.


From the department of preventive medicine

Latest:

Traditional risk factors across short-, intermediate-, and long-term follow-up in men and women

We found sex differences in the pattern of relative strength when riskfactor associations with death from cardiovascular disease (CVD) were evaluated across different periods of follow-up. In women, an increased risk in CVD-related death was associated with diabetes mellitus and smoking; this risk was most prominent in the early follow-up period. Our finding illustrates that clinicians should employ more intense preventive measures in women who are smokers or have diabetes.




R. Presley Swann, MD

Latest:

Managing Post-Operative Pain with Outpatient Procedures

R. Presley Swann, MD discussed his preference for CPNBs when treating his patient's post-operative pain.

© 2024 MJH Life Sciences

All rights reserved.